Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

T.K. Choueiri | Researchclopedia

Back to researchers

T.K. Choueiri

Dana-Farber Cancer Institute

11

Works

12

Citations

1

h-index

0

i10-index

Research Topics

Renal cell carcinoma treatment Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics

Affiliations

Dana-Farber Cancer Institute2022–2025

Dana-Farber Brigham Cancer Center2025–2025

Top Works

1690O NKT2152, a novel oral HIF-2α inhibitor, in participants (pts) with previously treated advanced clear cell renal carcinoma (accRCC): Preliminary results of a phase I/II study

Eric Jonasch,Bradley A. McGregor,et al.

20248 citations

Ferroptosis and cancer prognosis

Advanced Breast Cancer Therapies

1707P A plasma proteomic based algorithm is associated with prognosis in renal cell carcinoma

Eddy Saad,R.M. Saliby,et al.

20241 citations

Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER study

David Cella,Michael DeRosa,et al.

20251 citations

55 (PB043): Activity of CDK4/6 inhibitors in translocation renal cell carcinoma

Sumati Gupta,Pradeep Khanna,et al.

20241 citations

1464P The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)

V. Navani,M.S. Ernst,et al.

20221 citations

2606P Transcriptomic predictors of metastatic sites in renal cell carcinoma – a post-hoc analysis of the COSMIC-313 trial

Clara Steiner,Eddy Saad,et al.

20250 citations

2599MO Soluble MAdCAM-1 predicts outcomes in patients with metastatic renal cell carcinoma: Results from three independent clinical trials

Marc Machaalani,C. Alves Costa Silva,et al.

20250 citations

3108P Inflammatory biomarker panel predicting grade ≥2 neurotoxicity in Enfortumab Vedotin (EV) treated patients (pts)

Ilana Epstein,Bryn Russell,et al.

20250 citations

WITHDRAWN: 118P A framework for the evaluation of intermediate clinical endpoints of overall survival in real-world clinical data: Applications to metastatic breast cancer

C. Labaki,Z. Bakouny,et al.

20250 citations